Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo E Fiore

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Vascular Pharmacology|July 16, 2009
Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapiesRoberto A Mangiafico, Carmelo E Fiore
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Therapeutic perspectivesCarmelo E Fiore, Pietra Pennisi, Marianna Tinè
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2008
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)Alessandro Pecci, Antonio Granata, Carmelo E Fiore, et al.
Rheumatology International|September 1, 2006
Pamidronate and osteoporosis prevention in liver transplant recipientsPietra Pennisi, Andrea Trombetti, Emiliano Giostra, et al.
Diabetes & Vascular Disease Research|November 15, 2013
The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitusAgostino Gaudio, Filippo Privitera, Ivana Pulvirenti, et al.
Atherosclerosis|October 3, 2006
Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone massCarmelo E Fiore, Gabriella Celotta, Grazia G Politi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2010
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone lossAgostino Gaudio, Pietra Pennisi, Cornelia Bratengeier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Vascular Pharmacology|July 16, 2009
Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapiesRoberto A Mangiafico, Carmelo E Fiore
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Therapeutic perspectivesCarmelo E Fiore, Pietra Pennisi, Marianna Tinè
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2008
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)Alessandro Pecci, Antonio Granata, Carmelo E Fiore, et al.
Rheumatology International|September 1, 2006
Pamidronate and osteoporosis prevention in liver transplant recipientsPietra Pennisi, Andrea Trombetti, Emiliano Giostra, et al.
Diabetes & Vascular Disease Research|November 15, 2013
The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitusAgostino Gaudio, Filippo Privitera, Ivana Pulvirenti, et al.
Atherosclerosis|October 3, 2006
Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone massCarmelo E Fiore, Gabriella Celotta, Grazia G Politi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2010
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone lossAgostino Gaudio, Pietra Pennisi, Cornelia Bratengeier, et al.
Pageof 1